InvestorsHub Logo
Followers 58
Posts 7552
Boards Moderated 0
Alias Born 07/27/2012

Re: MoreThanWealth post# 41429

Wednesday, 03/13/2019 3:42:32 PM

Wednesday, March 13, 2019 3:42:32 PM

Post# of 55244
Found this:

THERAPY CELLS INC (OTCMKTS:TCEL) had an increase of 22100% in short interest. TCEL’s SI was 22,200 shares in March as released by FINRA. Its up 22100% from 100 shares previously. It closed at $0.0003 lastly. It is down 0.00% since March 13, 2018 and is . It has underperformed by 4.37% the S&P500.

Therapy Cells, Inc. develops and commercializes a technology for tendon repair for the human market. The company has market cap of $584,496. The Company’s technology is used for tissue transplantation to aid in the repair and regeneration of damaged, diseased, torn, or ruptured musculoskeletal cells and organs in the human, as well as to grow pancreatic cells, for treatment of diabetes, cardiac cells for the treatment of heart disease, and other cell types from various other tissues. It currently has negative earnings. The firm was formerly known as Diamond Information Institute, Inc. and changed its name to Therapy Cells, Inc. in May 2011.


https://livesadvice.com/2019/03/13/jp-morgan-cazenove-reconfirms-gbx-3500-00-target-price-per-share-on-derwent-london-londln-reconfirms-neutral-rating-therapy-cells-tcel-sellers-increased-by-22100-their-shorts/

gl